High Court to Review Myriad (MYGN) Patent on Genes
Go back to High Court to Review Myriad (MYGN) Patent on Genes| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 18.63 +0.03 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.60 | 52 Week High | $45.34 | |||
| Open | $18.54 | 52 Week Low | $15.92 | |||
| Day High | $18.84 | P/E | 8.00 | |||
| Day Low | $18.37 | EPS | $2.33 | |||
| Volume | 481,132 | |||||
